Preliminary results from the US Food and Drug Administration's (FDA's) mandated postmarket surveillance studies of duodenoscopes show "higher-than-expected" contamination rates after reprocessing, according to an article on the Medscape website.
The FDA said 3 percent of properly collected samples tested positive for more than 100 colony-forming units of "low-concern" organisms.
These organism are unlikely to cause serious infections but are, nevertheless, an indication of a "reprocessing failure."
An additional 3 percent of properly collected samples tested positive for "high-concern" bacteria that are more often associated with disease.
Silent Undercount: HAI Deaths Are Far Higher Than Reported
Ground Broken on Cleveland Clinic Avon Hospital Expansion Project in Ohio
Tennessee Oncology Opens New Tullahoma Medical Center
Rethinking Carpeting's Role in Senior Care Facilities
Parkview Health Breaks Ground on New Hospital in West Lafayette, IN